Hazen group to pursue research programs in atherosclerosis, thrombosis, obesity
Two new studies add insights and home in on therapeutic targets
Large cohort analysis shows benefits accrue even at extreme fitness levels
Mouse study shows most potent therapeutic ‘drugging’ of microbiome to date
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Prespecified analysis sheds light on a common real-world use scenario
Study’s genome-wide catalog should fuel investigations
ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes
Amount of HDL may be less important than previously thought
Advertisement
Advertisement